Download Word

Medtronic MRI-Conditional CRT-D Hospital Template Press Release
[HOSPITAL NAME] NOW OFFERS THE LATEST MRI-CONDITIONAL CARDIAC
RESYNCHONIZATION THERAPY DEFIBRILLATORS TO IMPROVE CARE FOR HEART
FAILURE PATIENTS
New CRT-Ds Allow Patients with Heart Failure to Safely Undergo Full Body MRI Scans
[Alternative subhead for hospitals using the full portfolio of Medtronic MRI-conditional cardiac
implantable electronic devices: Amplia MRI and Compia MRI CRT-Ds, Evera MRI ICDs,
Advisa MRI pacemakers and Reveal LINQ insertable cardiac monitors:
Patients with Serious Heart Conditions Now Have Access to All MRI-Conditional
Cardiac Implantable Devices from Medtronic, Can Safely Undergo Full Body MRI Scans
[CITY, DATE] – [Hospital Name] is now offering patients the first and only cardiac
resynchronization therapy defibrillators (CRT-Ds) approved by the FDA for use with magnetic
resonance imaging (MRI) scans. Designed to help the heart pump more effectively in a
coordinated rhythm, CRT-Ds are used to treat heart failure and help reduce the risk of sudden
cardiac arrest. Until now, however, patients with CRT-Ds have not been able to receive MRI
scans because of the potential for a harmful interaction between the MRI and the device. With
as many as 40 percent of CRT patients needing an MRI within four years of receiving a
device,1 thousands of patients implanted with CRT-Ds have not had access to MRI scans
when they needed them.
[Suggested Physician Quote]: “Our heart team is excited to be leading the way in improving
care for heart failure patients,” said [Hospital Physician/Spokesperson]. “Cardiac
resynchronization therapy is an important therapy option that has been shown to reduce
mortality and improve quality of life. Patients being treated for heart failure with these new MRconditional CRT-D devices will no longer be denied access to MRI scans, which can be critical
for doctors to detect and treat other underlying, potentially life-threatening conditions.”
One million people with heart failure are hospitalized each year in the U.S., and 25 percent of
them will be re-hospitalized within 30 days.2 Chronic heart failure occurs when the heart is
unable to pump enough blood to sustain adequate circulation in the body's tissues. CRT is a
cost-effective and beneficial therapy for indicated patients that helps the heart effectively pump
blood and oxygen to the body, reducing the risk of death and offering improvements in quality
of life for heart failure patients.
Allowing for MRI scans on any part of the body without positioning restrictions, the MRIconditional CRT-Ds from Medtronic, including the Amplia MRI™ Quad CRT-D SureScan® and
Medtronic MRI-Conditional CRT-D Hospital Template Press Release
Compia MRI™ Quad CRT-D SureScan® systems are designed to optimize therapy delivery.
Amplia MRI features the AdaptivCRT® algorithm, which has been shown to reduce a patient’s
odds of a heart failure readmission within 30 days by 59 percent,4 and reduce the risk of atrial
fibrillation by 46 percent.5
[Suggested content for hospitals using the full portfolio of Medtronic MRI-conditional cardiac
implantable electronic devices, including Amplia MRI and Compia MRI CRT-Ds, Evera MRI
ICD, Advisa MRI and Revo MRI pacemakers and Reveal LINQ insertable cardiac monitors:
[Hospital Name] now offers a complete portfolio of implantable cardiac devices including CRTDs, implantable cardioverter defibrillators (ICDs), pacemakers and insertable cardiac monitors
from Medtronic – all FDA approved for use with MRI scans – to provide care for patients with
heart failure, life-threatening arrhythmias or those at risk of sudden cardiac arrest.
For more information about the MRI-conditional CRT-Ds, please visit [hospital website] or call
[hospital number].
About [INSTITUTION NAME]
[INSERT INFORMATION ABOUT THE TREATING INSTITUTION]
-End1 Medtronic
data on file 2015: Data from MarketScan® 2012 Commercial and Medicare Database. Truven Health Analytics.
2 http://newsroom.heart.org/news/six-steps-could-cut-heart-failure-readmissions
3 Biffi
et al. Effort of Bipolar Electrode Spacing on Phrenic Nerve Stimulation and Left Ventricular Pacing Thresholds: An
Acute Canine Study. Circulation Arrhythmia and Electrophysiology. 2012.
4 Starling RC, Krum H, Bril S, Tsintzos SI, Rogers T, Hudnall JH, Martin DO. Impact of a Novel Adaptive Optimization
Algorithm on 30-Day Readmissions: Evidence from the Adaptive CRT Trial, JACC: Heart Failure (2015), doi:
10.1016/j.chf.2015.03.001.
5 Martin D, et al. Clinical Outcomes with Adaptive Cardiac Resynchronization Therapy: Long-term Outcomes of the Adaptive
CRT Trial. HFSA Late Breakers. September 23, 2013.